About Index Trending news
Analyze
Top 50 Pricing
CytomX Therapeutics

CytomX Therapeutics

Work at CytomX Therapeutics? Add yourself to this profile

CytomX Therapeutics

CytomX Therapeutics is an early-stage biotechnology company developing Probodies, proteolytically-activated antibodies.

Elsewhere

Alexa global traffic share

Latest funding Show all
Venture capital (Series C)
$20,000,000
Canaan Partners, Roche Venture Fund, Third Rock Ventures, +1
Venture capital (Series B)
$11,000,000
Employees

Team size

10+

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when CytomX Therapeutics makes some noise.